141 related articles for article (PubMed ID: 31151509)
1. Selective effects of ginseng pectins on galectin-3-mediated T cell activation and apoptosis.
Xue H; Zhao Z; Lin Z; Geng J; Guan Y; Song C; Zhou Y; Tai G
Carbohydr Polym; 2019 Sep; 219():121-129. PubMed ID: 31151509
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of Citrus segment membrane RG-I pectin against Galectin-3: The galactan is not the only important factor.
Wu D; Zheng J; Hu W; Zheng X; He Q; Linhardt RJ; Ye X; Chen S
Carbohydr Polym; 2020 Oct; 245():116526. PubMed ID: 32718630
[TBL] [Abstract][Full Text] [Related]
3. Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
Hossein G; Halvaei S; Heidarian Y; Dehghani-Ghobadi Z; Hassani M; Hosseini H; Naderi N; Sheikh Hassani S
Cancer Med; 2019 Aug; 8(9):4315-4329. PubMed ID: 31197964
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship.
Gao X; Zhi Y; Sun L; Peng X; Zhang T; Xue H; Tai G; Zhou Y
J Biol Chem; 2013 Nov; 288(47):33953-33965. PubMed ID: 24100038
[TBL] [Abstract][Full Text] [Related]
5. Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer.
Conti S; Vexler A; Hagoel L; Kalich-Philosoph L; Corn BW; Honig N; Shtraus N; Meir Y; Ron I; Eliaz I; Lev-Ari S
Integr Cancer Ther; 2018 Dec; 17(4):1225-1234. PubMed ID: 30043669
[TBL] [Abstract][Full Text] [Related]
6. Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury.
Kolatsi-Joannou M; Price KL; Winyard PJ; Long DA
PLoS One; 2011 Apr; 6(4):e18683. PubMed ID: 21494626
[TBL] [Abstract][Full Text] [Related]
7. The roles and mechanisms of homogalacturonan and rhamnogalacturonan I pectins on the inhibition of cell migration.
Fan Y; Sun L; Yang S; He C; Tai G; Zhou Y
Int J Biol Macromol; 2018 Jan; 106():207-217. PubMed ID: 28797814
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of Low-Molecular-Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells.
Wang S; Li P; Lu SM; Ling ZQ
Int J Biol Sci; 2016; 12(6):746-56. PubMed ID: 27194951
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of PectaSol-C modified citrus pectin an inhibitor of Galectin-3 and paclitaxel on apoptosis of human SKOV-3 ovarian cancer cells.
Hossein G; Keshavarz M; Ahmadi S; Naderi N
Asian Pac J Cancer Prev; 2013; 14(12):7561-8. PubMed ID: 24460334
[TBL] [Abstract][Full Text] [Related]
10. Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
Fang T; Liu DD; Ning HM; Dan Liu ; Sun JY; Huang XJ; Dong Y; Geng MY; Yun SF; Yan J; Huang RM
Acta Pharmacol Sin; 2018 Dec; 39(12):1885-1893. PubMed ID: 29769742
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3.
Gao X; Zhi Y; Zhang T; Xue H; Wang X; Foday AD; Tai G; Zhou Y
Glycoconj J; 2012 May; 29(4):159-65. PubMed ID: 22562786
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
[TBL] [Abstract][Full Text] [Related]
13. Macromolecular assemblies of complex polysaccharides with galectin-3 and their synergistic effects on function.
Zhang T; Miller MC; Zheng Y; Zhang Z; Xue H; Zhao D; Su J; Mayo KH; Zhou Y; Tai G
Biochem J; 2017 Nov; 474(22):3849-3868. PubMed ID: 28986508
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.
Wang L; Li YS; Yu LG; Zhang XK; Zhao L; Gong FL; Yang XX; Guo XL
Biochem Pharmacol; 2020 Aug; 178():114113. PubMed ID: 32579956
[TBL] [Abstract][Full Text] [Related]
15. Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells.
Abu-Elsaad NM; Elkashef WF
Can J Physiol Pharmacol; 2016 May; 94(5):554-62. PubMed ID: 27010252
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative and proapoptotic actions of okra pectin on B16F10 melanoma cells.
Vayssade M; Sengkhamparn N; Verhoef R; Delaigue C; Goundiam O; Vigneron P; Voragen AG; Schols HA; Nagel MD
Phytother Res; 2010 Jul; 24(7):982-9. PubMed ID: 20013817
[TBL] [Abstract][Full Text] [Related]
17. Structural Characterization of a Rhamnogalacturonan I Domain from Ginseng and Its Inhibitory Effect on Galectin-3.
Shi H; Yu L; Shi Y; Lu J; Teng H; Zhou Y; Sun L
Molecules; 2017 Jun; 22(6):. PubMed ID: 28629160
[TBL] [Abstract][Full Text] [Related]
18. Analysis of pectin from Panax ginseng flower buds and their binding activities to galectin-3.
Cui L; Wang J; Huang R; Tan Y; Zhang F; Zhou Y; Sun L
Int J Biol Macromol; 2019 May; 128():459-467. PubMed ID: 30703424
[TBL] [Abstract][Full Text] [Related]
19. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
[TBL] [Abstract][Full Text] [Related]
20. RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways.
Zhang L; Wang P; Qin Y; Cong Q; Shao C; Du Z; Ni X; Li P; Ding K
Oncogene; 2017 Mar; 36(9):1297-1308. PubMed ID: 27617577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
